Effects of dietary saw palmetto on the prostate of transgenic adenocarcinoma of the mouse prostate model (TRAMP)

Teri L. Wadsworth, Teresa R. Worstell, Norman M. Greenberg, Charles Roselli

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

BACKGROUND. Several of the proposed mechanisms for the actions of the liposterolic extract of saw palmetto (SPE) are exerted on known risk factors for prostate cancer (CaP). This study investigated whether SPE could prevent the progression of CaP in a transgenic adenocarcinoma of the mouse prostate (TRAMP) model. METHODS. Two different doses of SPE designed to deliver 50 mg/kg/day SPE and 300 mg/kg/day SPE were administered in a custom diet to TRAMP mice for 12 or 24 weeks. Body and organ weights were used to evaluate toxicity, and radioimmunoassay was used to measure plasma and tissue androgen levels to monitor effects of SPE on 5α reductase activity. Prostate tissues were evaluated histologically to determine the effect of treatment on tumor grade, cell proliferation, and apoptosis. RESULTS. Treatment with 300 mg/kg/day SPE from 4 to 24 weeks of age significantly reduced the concentration of 5α-dihydrotestosterone (DHT) in the prostate and resulted in a significant increase in apoptosis and significant decrease in pathological tumor grade and frank tumor incidence. CONCLUSIONS. Dietary supplementation with SPE may be effective in controlling CaP tumorigenesis. SPE suppression of prostatic DHT levels lends support to the hypothesis that inhibition of the enzyme 5α-reductase is a mechanism of action of this substance.

Original languageEnglish (US)
Pages (from-to)661-673
Number of pages13
JournalProstate
Volume67
Issue number6
DOIs
StatePublished - May 1 2007

Fingerprint

Transgenic Mice
Prostate
Adenocarcinoma
Dihydrotestosterone
Oxidoreductases
Apoptosis
Neoplasms
Organ Size
Dietary Supplements
Androgens
Radioimmunoassay
Prostatic Neoplasms
Carcinogenesis
Body Weight
Cell Proliferation
Diet
Incidence
Enzymes

Keywords

  • 5α-reductase
  • Apoptosis
  • Ki67
  • Prostate cancer
  • Serenoa repens

ASJC Scopus subject areas

  • Urology

Cite this

Effects of dietary saw palmetto on the prostate of transgenic adenocarcinoma of the mouse prostate model (TRAMP). / Wadsworth, Teri L.; Worstell, Teresa R.; Greenberg, Norman M.; Roselli, Charles.

In: Prostate, Vol. 67, No. 6, 01.05.2007, p. 661-673.

Research output: Contribution to journalArticle

Wadsworth, Teri L. ; Worstell, Teresa R. ; Greenberg, Norman M. ; Roselli, Charles. / Effects of dietary saw palmetto on the prostate of transgenic adenocarcinoma of the mouse prostate model (TRAMP). In: Prostate. 2007 ; Vol. 67, No. 6. pp. 661-673.
@article{982d4e49be43441b8bf96a6b187ac7bd,
title = "Effects of dietary saw palmetto on the prostate of transgenic adenocarcinoma of the mouse prostate model (TRAMP)",
abstract = "BACKGROUND. Several of the proposed mechanisms for the actions of the liposterolic extract of saw palmetto (SPE) are exerted on known risk factors for prostate cancer (CaP). This study investigated whether SPE could prevent the progression of CaP in a transgenic adenocarcinoma of the mouse prostate (TRAMP) model. METHODS. Two different doses of SPE designed to deliver 50 mg/kg/day SPE and 300 mg/kg/day SPE were administered in a custom diet to TRAMP mice for 12 or 24 weeks. Body and organ weights were used to evaluate toxicity, and radioimmunoassay was used to measure plasma and tissue androgen levels to monitor effects of SPE on 5α reductase activity. Prostate tissues were evaluated histologically to determine the effect of treatment on tumor grade, cell proliferation, and apoptosis. RESULTS. Treatment with 300 mg/kg/day SPE from 4 to 24 weeks of age significantly reduced the concentration of 5α-dihydrotestosterone (DHT) in the prostate and resulted in a significant increase in apoptosis and significant decrease in pathological tumor grade and frank tumor incidence. CONCLUSIONS. Dietary supplementation with SPE may be effective in controlling CaP tumorigenesis. SPE suppression of prostatic DHT levels lends support to the hypothesis that inhibition of the enzyme 5α-reductase is a mechanism of action of this substance.",
keywords = "5α-reductase, Apoptosis, Ki67, Prostate cancer, Serenoa repens",
author = "Wadsworth, {Teri L.} and Worstell, {Teresa R.} and Greenberg, {Norman M.} and Charles Roselli",
year = "2007",
month = "5",
day = "1",
doi = "10.1002/pros.20552",
language = "English (US)",
volume = "67",
pages = "661--673",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Effects of dietary saw palmetto on the prostate of transgenic adenocarcinoma of the mouse prostate model (TRAMP)

AU - Wadsworth, Teri L.

AU - Worstell, Teresa R.

AU - Greenberg, Norman M.

AU - Roselli, Charles

PY - 2007/5/1

Y1 - 2007/5/1

N2 - BACKGROUND. Several of the proposed mechanisms for the actions of the liposterolic extract of saw palmetto (SPE) are exerted on known risk factors for prostate cancer (CaP). This study investigated whether SPE could prevent the progression of CaP in a transgenic adenocarcinoma of the mouse prostate (TRAMP) model. METHODS. Two different doses of SPE designed to deliver 50 mg/kg/day SPE and 300 mg/kg/day SPE were administered in a custom diet to TRAMP mice for 12 or 24 weeks. Body and organ weights were used to evaluate toxicity, and radioimmunoassay was used to measure plasma and tissue androgen levels to monitor effects of SPE on 5α reductase activity. Prostate tissues were evaluated histologically to determine the effect of treatment on tumor grade, cell proliferation, and apoptosis. RESULTS. Treatment with 300 mg/kg/day SPE from 4 to 24 weeks of age significantly reduced the concentration of 5α-dihydrotestosterone (DHT) in the prostate and resulted in a significant increase in apoptosis and significant decrease in pathological tumor grade and frank tumor incidence. CONCLUSIONS. Dietary supplementation with SPE may be effective in controlling CaP tumorigenesis. SPE suppression of prostatic DHT levels lends support to the hypothesis that inhibition of the enzyme 5α-reductase is a mechanism of action of this substance.

AB - BACKGROUND. Several of the proposed mechanisms for the actions of the liposterolic extract of saw palmetto (SPE) are exerted on known risk factors for prostate cancer (CaP). This study investigated whether SPE could prevent the progression of CaP in a transgenic adenocarcinoma of the mouse prostate (TRAMP) model. METHODS. Two different doses of SPE designed to deliver 50 mg/kg/day SPE and 300 mg/kg/day SPE were administered in a custom diet to TRAMP mice for 12 or 24 weeks. Body and organ weights were used to evaluate toxicity, and radioimmunoassay was used to measure plasma and tissue androgen levels to monitor effects of SPE on 5α reductase activity. Prostate tissues were evaluated histologically to determine the effect of treatment on tumor grade, cell proliferation, and apoptosis. RESULTS. Treatment with 300 mg/kg/day SPE from 4 to 24 weeks of age significantly reduced the concentration of 5α-dihydrotestosterone (DHT) in the prostate and resulted in a significant increase in apoptosis and significant decrease in pathological tumor grade and frank tumor incidence. CONCLUSIONS. Dietary supplementation with SPE may be effective in controlling CaP tumorigenesis. SPE suppression of prostatic DHT levels lends support to the hypothesis that inhibition of the enzyme 5α-reductase is a mechanism of action of this substance.

KW - 5α-reductase

KW - Apoptosis

KW - Ki67

KW - Prostate cancer

KW - Serenoa repens

UR - http://www.scopus.com/inward/record.url?scp=34247626242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247626242&partnerID=8YFLogxK

U2 - 10.1002/pros.20552

DO - 10.1002/pros.20552

M3 - Article

C2 - 17342743

AN - SCOPUS:34247626242

VL - 67

SP - 661

EP - 673

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 6

ER -